Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different bupivacaine volumes for ultrasound-guided rhomboid intercostal block after modified radical mastectomy
PACTR202306811590520Recruiting
- Sponsor
- Mansoura University Hospitals
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain and breast cancer (2 arms), sponsored by Mansoura University Hospitals. Primary endpoint: Total analgesic requirements during the first 24 hours postoperative. Started Jul 2021; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative painbreast cancer
Beyond the preview
Go deeper on PACTR202306811590520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202306811590520.